In 2021, the global endotherapy devices market reached a value of around four billion U.S. dollars. It is expected to reach seven billion dollars by 2028. This statistic depicts the size of the endotherapy devices market worldwide.

Endotherapy Devices Market by Type (Needles, Biopsy Forceps, Balloon Dilators, Haemostasias, Snares, Catheters, Sphincterotomes, Guide Wires, Stents, Retrieval Net), Application (Upper GI Endoscopy, Colonoscopy, Cystoscopy) - Global Forecast to 2032

Endotherapy Devices Market size was valued at $3.84 billion in 2019 and is predicted to reach $6.63 billion by 2030 with a CAGR of 5.1% from 2020-2030

Global Endotherapy Devices market size will be USD 6.59 Billion by 2030. Endotherapy Devices Industry's Compound Annual Growth Rate will be 6.02% from 2023 to 2030.

Global Respiratory Endotherapy Devices Market has valued at USD 1.45 Billion in 2024 and is anticipated to project robust growth in the forecast period with a CAGR of 5.33% through 2030.

Learn more about Market Research Intellect's Endotherapy Devices Market Report, valued at USD 7.80 billion in 2024, and set to grow to USD 12.50 billion by 2033 with a CAGR of 6.5% (2026-2033).

Endotherapy Devices Market Outlook

The global endotherapy devices market size is anticipated to experience significant growth, reaching approximately USD 12 billion by 2023 and is projected to expand further to USD 18 billion by 2032, at a compound annual growth rate (CAGR) of 5%. This growth is primarily driven by advancements in medical technologies, an increasing prevalence of gastrointestinal disorders, and a growing demand for minimally invasive procedures. The rising aging population and increased healthcare expenditure in developing economies also contribute significantly to the market expansion. Furthermore, the continual development of innovative endotherapy devices and enhancements in surgical techniques are further propelling the market growth.

The escalating prevalence of chronic diseases, particularly gastrointestinal disorders, is a major growth factor for the endotherapy devices market. As lifestyles have become more sedentary and diets have changed, there has been a notable increase in conditions such as colorectal cancer, Crohn's disease, and irritable bowel syndrome. Such conditions often require diagnostic and therapeutic endoscopy, thereby driving the demand for endotherapy devices. Moreover, the shift towards minimally invasive surgical procedures is boosting the adoption of endotherapy devices, as these procedures are associated with reduced recovery times, less post-operative pain, and lower risk of complications, making them more appealing to patients and healthcare providers alike.

Technological advancements in the field of endotherapy are another significant factor contributing to market growth. Innovations such as high-definition imaging, narrow-band imaging, and robotic endoscopy are enhancing the precision and effectiveness of diagnostic and therapeutic procedures. These technological improvements are resulting in better patient outcomes and are encouraging healthcare facilities to invest in the latest endotherapy devices. Additionally, the integration of artificial intelligence in endoscopy is expected to revolutionize the way endoscopic procedures are performed, providing real-time decision support to endoscopists, which in turn is likely to boost the market further.

The increase in healthcare expenditure and improved healthcare infrastructure in emerging economies also play a crucial role in the growth of the endotherapy devices market. Governments in these regions are investing more in healthcare facilities, which is leading to the establishment of more hospitals and specialty clinics equipped with advanced medical technologies, including endotherapy devices. This trend is increasing access to quality healthcare and expanding the market reach in these regions. Furthermore, the rising awareness among the population regarding early diagnosis and treatment of gastrointestinal conditions is contributing to the growth of the market.

Endoscopic Retrograde Cholangiopancreatography Devices play a crucial role in the diagnosis and treatment of pancreatic and biliary diseases. These devices are specifically designed to facilitate access to the bile and pancreatic ducts, allowing for precise interventions. The growing prevalence of conditions such as gallstones, pancreatitis, and bile duct strictures has led to an increased demand for ERCP procedures. As a result, manufacturers are focusing on developing advanced ERCP devices that offer enhanced maneuverability, improved visualization, and greater safety. The integration of innovative technologies, such as digital imaging and single-use devices, is further enhancing the efficacy of ERCP procedures, making them more accessible and effective for patients worldwide.

Regionally, North America is expected to hold a significant share of the endotherapy devices market owing to the presence of a well-established healthcare system, high adoption rate of advanced technology, and significant expenditure on healthcare. Moreover, the ongoing research and development activities, along with a large patient pool suffering from chronic diseases, further foster market growth. Europe is also anticipated to exhibit substantial growth due to rising government initiatives to improve healthcare services and the implementation of favorable reimbursement policies. The Asia Pacific region is projected to witness the highest growth rate, attributed to the increasing prevalence of gastrointestinal diseases, improving healthcare infrastructure, and growing awareness regarding minimally invasive procedures.

Global Endotherapy Devices market size is expected to reach $6.64 billion by 2029 at 7.9%, surge in gastrointestinal diseases and the ascendancy of endotherapy devices in medical interventions

North America Respiratory Endotherapy Devices comes with extensive industry analysis of development components, patterns, flows, and sizes. The report calculates present and past market values to forecast potential market management during the forecast period between 2025 - 2033.

North America Endotherapy Devices Market is expected to grow during 2025-2031

The Japan Endotherapy Devices market reached US$ 2.70 billion in 2023 and is expected to reach US$ 4.44 billion by 2031

The North America Endotherapy Devices report features an extensive regional analysis, identifying market penetration levels across major geographic areas. It highlights regional growth trends and opportunities, allowing businesses to tailor their market entry strategies and maximize growth in specific regions.

Africa Endotherapy Devices Market is expected to grow during 2025-2031

The global respiratory endotherapy devices market is experiencing steady growth, projected to maintain a Compound Annual Growth Rate (CAGR) of 5% from 2025 to 2033. While the exact market size in 2025 is not provided, considering the average growth rate and typical market sizes for similar medical device sectors, a reasonable estimate would place the market value at approximately $2.5 billion in 2025. This growth is driven by several key factors, including the rising prevalence of respiratory diseases like asthma, COPD, and lung cancer, an aging global population with increased susceptibility to these conditions, and advancements in minimally invasive endotherapy procedures. Technological innovations resulting in smaller, more precise, and less invasive devices are also significantly contributing to market expansion. Furthermore, the increasing demand for efficient and effective treatment options, coupled with improved healthcare infrastructure in developing economies, is fueling market growth. However, the market faces certain challenges. High costs associated with these advanced devices and procedures, stringent regulatory approvals required for new product launches, and potential reimbursement challenges in some healthcare systems act as restraints. Nevertheless, the increasing focus on improving patient outcomes, coupled with ongoing research and development efforts leading to innovative solutions, is expected to overcome these hurdles and drive continued market expansion throughout the forecast period. The market segmentation, encompassing various device types and therapeutic applications, further contributes to the complexity and diversity of this dynamic landscape. Major players like Fujifilm Holdings, Medtronic, Johnson & Johnson, Smith & Nephew, and Stryker Corporation are actively involved in shaping this market through continuous innovation and strategic acquisitions.

Report of Respiratory Endotherapy Devices Market is currently supplying a comprehensive analysis of many things which are liable for economy growth and factors which could play an important part in the increase of the marketplace in the prediction period. The record of Respiratory Endotherapy Devices Industry is providing the thorough study on the grounds of market revenue discuss production and price happened. The report also provides the overview of the segmentation on the basis of area, contemplating the particulars of earnings and sales pertaining to marketplace.

Report of Endotherapy Devices is covering the summarized study of several factors encouraging the growth of the market such as market size, market type, major regions and end user applications. By using the report customer can recognize the several drivers that impact and govern the market. The report is describing the several types of Endotherapy Devices Industry. Factors that are playing the major role for growth of specific type of product category and factors that are motivating the status of the market.

Middle East Endotherapy Devices Market is expected to grow during 2025-2031

The ERCP (Endoscopic Retrograde Cholangiopancreatography) equipment market is experiencing robust growth, driven by rising prevalence of biliary and pancreatic diseases, technological advancements in endoscopy, and increasing demand for minimally invasive procedures. The market, estimated at $1.5 billion in 2025, is projected to exhibit a Compound Annual Growth Rate (CAGR) of 7% from 2025 to 2033, reaching approximately $2.8 billion by 2033. Key drivers include the aging global population, increasing incidence of gastrointestinal cancers, and a shift towards outpatient procedures. Technological innovations such as improved visualization systems, advanced energy devices, and single-use endoscopes are fueling market expansion. The segment encompassing endoscopes holds the largest market share, followed by visualization systems and endotherapy devices. Hospitals and ambulatory surgery centers are the primary end-users, reflecting the preference for specialized facilities equipped for complex procedures. However, market growth is constrained by high equipment costs, stringent regulatory approvals, and the need for skilled professionals to operate the sophisticated equipment. Competition is fierce among established players like Olympus, Fujifilm, and Boston Scientific, as well as emerging companies offering innovative solutions. Regional growth varies, with North America and Europe currently dominating the market due to advanced healthcare infrastructure and high adoption rates. However, Asia Pacific is anticipated to experience significant growth in the forecast period due to expanding healthcare budgets and rising awareness of advanced medical treatments. The competitive landscape is characterized by both established multinational corporations and specialized medical device manufacturers. Strategic partnerships, mergers, and acquisitions are expected to increase, further shaping the market dynamics. The market is segmented by application (hospitals, ambulatory surgery centers, clinics, others), type (endoscopes, endotherapy devices, visualization systems, energy devices, others), and geography. Future growth will be influenced by factors including the development of artificial intelligence (AI)-powered diagnostic tools, the introduction of robotic-assisted ERCP systems, and the increasing emphasis on improving patient outcomes through better visualization and precision during procedures. This market analysis suggests that investment in research and development, coupled with strategic market expansion, will be crucial for companies seeking to capitalize on the growing demand for advanced ERCP equipment.

The Endotherapy Devices market is experiencing significant growth as healthcare professionals increasingly integrate advanced medical technologies into various therapeutic procedures. Endotherapy devices, which include tools used during minimally invasive surgeries for diagnosis and treatment, are essential in gastr

The Respiratory Endotherapy Devices market has emerged as a crucial sector within the medical device industry, focusing on the treatment and management of respiratory diseases through minimally invasive techniques. These devices are primarily used for procedures such as biopsies, bronchial drainage, and stent placem